Cortigent, Inc. engages in the development of neurostimulation systems to help patients recover critical body functions. The company’s technology combines neuroscience with microelectronics, software, and data processing capabilities to provide artificial vision and restore muscle movement. The company develops include Argus II, a retinal implant to provide vision to people blind due to retinitis pigmentosa. It offers Orion, a Visual Cortical Prosthesis System to provide artificial vision to people who are blind due to glaucoma and diabetic retinopathy. Additionally, it develops Stroke Recovery System, a medical device for the recovery of arm and hand movement in people who have suffered paralysis due to stroke. The company was founded in 1998 and is based in Valencia, California. Cortigent, Inc. operates as a subsidiary of Vivani Medical, Inc.
Metrics to compare | CRGT | Peers Peers - average of corresponding metrics from companies closely matching CRGT: | Sector Sector - Average of metrics from a broad group of related sector companies | Relationship RelationshipCRGTPeersSector |
|---|---|---|---|---|
P/E Ratio | Unlock | NaN | NaN | Unlock |
PEG Ratio | Unlock | NaN | NaN | Unlock |
Price/Book | Unlock | NaN | NaN | Unlock |
Price / LTM Sales | Unlock | NaN | NaN | Unlock |
Upside (Analyst Target) | Unlock | NaN | NaN | Unlock |
Fair Value Upside | Unlock | NaN | NaN | Unlock |